ZYXI 1.47 ▲ 1.38% Live Trading Data - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Zynex Inc.

    NASDAQ: ZYXI · Real-Time Price · USD
    1.47
    0.02 (1.38%)
    At close: Oct 03, 2025, 3:59 PM
    1.48
    0.68%
    After-hours: Oct 03, 2025, 04:46 PM EDT
    1.38%
    Bid 1.41
    Market Cap 44.54M
    Revenue (ttm) 144.81M
    Net Income (ttm) -28.66M
    EPS (ttm) -0.93
    PE Ratio (ttm) -1.58
    Forward PE -3.22
    Analyst Hold
    Dividends n/a
    Ask 1.5
    Volume 71,286
    Avg. Volume (20D) 244,387
    Open 1.44
    Previous Close 1.45
    Day's Range 1.44 - 1.49
    52-Week Range 1.23 - 9.42
    Beta 1.10
    Ex-Dividend Date n/a

    About ZYXI

    undefined

    [Read more]
    Industry n/a
    Sector n/a
    IPO Date n/a
    Employees NaN
    Stock Exchange n/a
    Ticker Symbol ZYXI
    Website n/a
    Full Company Profile

    Analyst Forecast

    According to 0 analyst ratings, the average rating for ZYXI stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

    Stock Forecasts

    Next Earnings Release

    Zynex Inc. is scheduled to release its earnings on Oct 23, 2025, after market closes.
    Analysts project revenue of ... Unlock content with Pro Subscription
    2 months ago
    -43.5%
    Zynex shares are trading lower after the company r... Unlock content with Pro Subscription
    2 months ago
    -10.44%
    Zynex shares are trading lower after the company reported worse-than-expected Q2 financial results.
    news image

    1 month ago · proactiveinvestors.com

    Zynex welcomes Steve Dyson as CEO, adds to leadership team

    Zynex Inc (NASDAQ:ZYXI), a medical technology company specializing in non-invasive devices for pain management, rehabilitation, and patient monitoring, announced the arrival of Steven Dyson as its new...

    news image

    2 months ago · fool.com

    Zynex Q2 Revenue Drops 55%

    Zynex Q2 Revenue Drops 55%

    news image

    2 months ago · seekingalpha.com

    Zynex, Inc. (ZYXI) Q2 2025 Earnings Call Transcript

    Zynex, Inc. (NASDAQ:ZYXI ) Q2 2025 Earnings Conference Call July 31, 2025 4:15 PM ET Company Participants Anna Lucsok - Chief Operating Officer Daniel J. Moorhead - Chief Financial Officer Donald Greg...

    news image

    2 months ago · zacks.com

    Zynex Inc. (ZYXI) Reports Q2 Loss, Misses Revenue Estimates

    Zynex Inc. (ZYXI) came out with a quarterly loss of $0.32 per share versus the Zacks Consensus Estimate of a loss of $0.2. This compares to earnings of $0.04 per share a year ago.

    news image

    2 months ago · proactiveinvestors.com

    Zynex eyes growth revival under new CEO, advances oximeter technology

    Zynex Inc (NASDAQ:ZYXI), a developer of non-invasive medical devices, is laying the foundation for a return to growth following a pivotal second quarter marked by leadership changes, operational strea...

    news image

    2 months ago · proactiveinvestors.com

    Zynex: New CEO Steven Dyson shares his vision – ICYMI

    Zynex Inc (NASDAQ:ZYXI) earlier this week outlined changes to its leadership as Thomas Sandgaard prepares to move into the chairman role. The company said Steven Dyson will step in as the new chief ex...

    news image

    3 months ago · proactiveinvestors.com

    Zynex CEO Thomas Sandgaard discusses leadership transition - ICYMI

    Zynex Inc (NASDAQ:ZYXI) CEO Thomas Sandgaard talked with Proactive about his decision to step down from his position after nearly three decades leading the medical device company. He described the cha...

    Add to Watchlist